Vanguard Group Inc Bionano Genomics, Inc. Transaction History

Vanguard Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.57 - $1.16 $1.08 Million - $2.2 Million	-1,894,016 Reduced 11.54%	14,516,927 $8.86 Million
Q1 2023 May 15, 2023	BUY	$1.06 - $1.97 $367,288 - $682,603	346,499 Added 2.16%	16,410,943 $18.2 Million
Q4 2022 Feb 10, 2023	BUY	$1.4 - $25.4 $447,601 - $8.12 Million	319,715 Added 2.03%	16,064,444 $23.5 Million
Q3 2022 Nov 14, 2022	BUY	$0.36 - $36.0 $39,719 - $3.97 Million	110,332 Added 0.71%	15,744,729 $28.8 Million
Q2 2022 Aug 12, 2022	SELL	$12.3 - $27.3 $2.98 Million - $6.6 Million	-241,892 Reduced 1.52%	15,634,397 $21.6 Million
Q1 2022 May 13, 2022	BUY	$16.6 - $32.3 $17.4 Million - $33.9 Million	1,050,655 Added 7.09%	15,876,289 $41 Million
Q4 2021 Feb 14, 2022	SELL	$29.9 - $61.2 $6.81 Million - $13.9 Million	-227,638 Reduced 1.51%	14,825,634 $44.3 Million
Q3 2021 Nov 12, 2021	BUY	$51.4 - $68.2 $10.2 Million - $13.5 Million	197,836 Added 1.33%	15,053,272 $82.8 Million
Q2 2021 Aug 13, 2021	BUY	$44.1 - $84.0 $655 Million - $1.25 Billion	14,855,436 New	14,855,436 $109 Million

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $58M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.